BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34555648)

  • 1. Longitudinal prognostication in retroperitoneal sarcoma survivors: Development and external validation of two dynamic nomograms.
    Callegaro D; Barretta F; Swallow CJ; Strauss DC; Bonvalot S; Honorè C; Stoeckle E; van Coevorden F; Haas R; Rutkowski P; Schrage Y; Fairweather M; Conti L; Vassos N; Gladdy RA; Ng D; van Houdt WJ; Miceli R; Raut CP; Gronchi A
    Eur J Cancer; 2021 Nov; 157():291-300. PubMed ID: 34555648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External validation of a multi-institutional retroperitoneal sarcoma nomogram.
    Raut CP; Miceli R; Strauss DC; Swallow CJ; Hohenberger P; van Coevorden F; Rutkowski P; Fiore M; Callegaro D; Casali PG; Haas RL; Hayes AJ; Honore C; Cannell AJ; Jakob J; Szacht M; Fairweather M; Pollock RE; Bonvalot S; Gronchi A
    Cancer; 2016 May; 122(9):1417-24. PubMed ID: 26916507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG.
    Raut CP; Callegaro D; Miceli R; Barretta F; Rutkowski P; Blay JY; Lahat G; Strauss DC; Gonzalez R; Ahuja N; Grignani G; Quagliuolo V; Stoeckle E; De Paoli A; Pillarisetty VG; Nessim C; Swallow CJ; Bagaria S; Canter R; Mullen J; Gelderblom HJ; Pennacchioli E; van Coevorden F; Cardona K; Fiore M; Fairweather M; Gronchi A
    Clin Cancer Res; 2019 Apr; 25(8):2664-2671. PubMed ID: 30723141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets.
    Gronchi A; Miceli R; Shurell E; Eilber FC; Eilber FR; Anaya DA; Kattan MW; Honoré C; Lev DC; Colombo C; Bonvalot S; Mariani L; Pollock RE
    J Clin Oncol; 2013 May; 31(13):1649-55. PubMed ID: 23530096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis.
    Callegaro D; Miceli R; Bonvalot S; Ferguson P; Strauss DC; Levy A; Griffin A; Hayes AJ; Stacchiotti S; Pechoux CL; Smith MJ; Fiore M; Dei Tos AP; Smith HG; Mariani L; Wunder JS; Pollock RE; Casali PG; Gronchi A
    Lancet Oncol; 2016 May; 17(5):671-80. PubMed ID: 27068860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multi-institutional validation study of prognostic nomograms for retroperitoneal sarcoma.
    Squires MH; Ethun CG; Donahue EE; Benbow JH; Anderson CJ; Jagosky MH; Salo JC; Hill JS; Ahrens W; Prabhu RS; Livingston MB; Gower NL; Needham M; Trufan SJ; Fields RC; Krasnick BA; Bedi M; Abbott DE; Schwartz P; Votanopoulos K; Chouliaras K; Grignol V; Roggin KK; Tseng J; Poultsides G; Tran TB; Cardona K; Howard JH
    J Surg Oncol; 2021 Oct; 124(5):829-837. PubMed ID: 34254691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and external validation of a dynamic prognostic nomogram for primary extremity soft tissue sarcoma survivors.
    Callegaro D; Miceli R; Bonvalot S; Ferguson PC; Strauss DC; van Praag VVM; Levy A; Griffin AM; Hayes AJ; Stacchiotti S; Pèchoux CL; Smith MJ; Fiore M; Tos APD; Smith HG; Catton C; Szkandera J; Leithner A; van de Sande MAJ; Casali PG; Wunder JS; Gronchi A
    EClinicalMedicine; 2019 Dec; 17():100215. PubMed ID: 31891146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative nomogram for survival of patients with retroperitoneal sarcoma treated with curative intent.
    Anaya DA; Lahat G; Wang X; Xiao L; Pisters PW; Cormier JN; Hunt KK; Feig BW; Lev DC; Pollock RE
    Ann Oncol; 2010 Feb; 21(2):397-402. PubMed ID: 19622598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nomogram development and external validation for predicting overall survival and cancer-specific survival in patients with primary retroperitoneal sarcoma: a retrospective cohort study.
    Zheng J; Zhuang A; Xia X; Miao F; Wang Z; Kong X; Ren Y; Ma Y; Lin Z; Lu W; Li W
    Discov Oncol; 2023 Nov; 14(1):197. PubMed ID: 37910291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Sarculator Prognostic Nomograms for Patients With Primary Retroperitoneal Sarcoma: Case Volume Does Matter.
    Callegaro D; Barretta F; Raut CP; Johnston W; Strauss DC; Honoré C; Bonvalot S; Fairweather M; Rutkowski P; van Houdt WJ; Gladdy RA; Tirotta F; Tzanis D; Skoczylas J; Haas RL; Miceli R; Swallow CJ; Gronchi A
    Ann Surg; 2024 May; 279(5):857-865. PubMed ID: 37753660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applicability of the Sarculator and MSKCC nomograms to retroperitoneal sarcoma prognostication in an Asian tertiary center.
    Wong RX; Koh YS; Ong F; Farid M; Tay TKY; Teo M
    Asian J Surg; 2020 Nov; 43(11):1078-1085. PubMed ID: 31941593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS): A Report on 1007 Patients From the Multi-institutional Collaborative RPS Working Group.
    Gronchi A; Strauss DC; Miceli R; Bonvalot S; Swallow CJ; Hohenberger P; Van Coevorden F; Rutkowski P; Callegaro D; Hayes AJ; Honoré C; Fairweather M; Cannell A; Jakob J; Haas RL; Szacht M; Fiore M; Casali PG; Pollock RE; Raut CP
    Ann Surg; 2016 May; 263(5):1002-9. PubMed ID: 26727100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Preoperative Treatment on the Performance of Predictive Nomograms in Primary Retroperitoneal Sarcoma.
    Ng D; Cyr DP; Burtenshaw SM; Callegaro D; Gronchi A; Shultz D; Brar S; Chung P; Gladdy RA; Catton C; Swallow CJ
    Ann Surg Oncol; 2022 Apr; 29(4):2304-2314. PubMed ID: 35022902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of postoperative radiological surveillance intensity on disease free and overall survival from primary retroperitoneal, abdominal and pelvic soft-tissue sarcoma.
    Glasbey JC; Bundred J; Tyler R; Hunt J; Tattersall H; Gourevitch D; Almond LM; Desai AD; Ford SJ
    Eur J Surg Oncol; 2021 Jul; 47(7):1771-1777. PubMed ID: 33549374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External validation and adaptation of a dynamic prediction model for patients with high-grade extremity soft tissue sarcoma.
    Rueten-Budde AJ; van Praag VM; van de Sande MAJ; Fiocco M;
    J Surg Oncol; 2021 Mar; 123(4):1050-1056. PubMed ID: 33332599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the Trans-Atlantic RPS Working Group.
    MacNeill AJ; Miceli R; Strauss DC; Bonvalot S; Hohenberger P; Van Coevorden F; Rutkowski P; Callegaro D; Hayes AJ; Honoré C; Fairweather M; Cannell A; Jakob J; Haas RL; Szacht M; Fiore M; Casali PG; Pollock RE; Raut CP; Gronchi A; Swallow CJ
    Cancer; 2017 Jun; 123(11):1971-1978. PubMed ID: 28152173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histology-specific nomogram for primary retroperitoneal soft tissue sarcoma.
    Ardoino I; Miceli R; Berselli M; Mariani L; Biganzoli E; Fiore M; Collini P; Stacchiotti S; Casali PG; Gronchi A
    Cancer; 2010 May; 116(10):2429-36. PubMed ID: 20209615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and Outcomes of Locally Recurrent Retroperitoneal Sarcoma After First Relapse in a Single Tertiary Asian Centre and Applicability of the
    Lim HJ; Wong R; Koh YS; Ho ZS; Ong CJ; Farid M; Teo CCM
    Front Oncol; 2021; 11():730292. PubMed ID: 34900680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival nomograms for patients with retroperitoneal soft tissue sarcoma based on the SEER database and an external cohort.
    Wu J; Zhang Y; Yao G; Tuersunmaimaiti A; Azhati Y; Mamuti A; Wen H; Tuxun T
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):15013-15026. PubMed ID: 37610674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nomogram to predict overall survival and disease-free survival after curative resection of gastric adenocarcinoma.
    Kim Y; Spolverato G; Ejaz A; Squires MH; Poultsides G; Fields RC; Bloomston M; Weber SM; Votanopoulos K; Acher AW; Jin LX; Hawkins WG; Schmidt C; Kooby D; Worhunsky D; Saunders N; Levine EA; Cho CS; Maithel SK; Pawlik TM
    Ann Surg Oncol; 2015; 22(6):1828-35. PubMed ID: 25388061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.